Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism C5AR1 antagonists(C5a anaphylatoxin chemotactic receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Disorder of Complement | Phase 1 | US | - | |
Hereditary Complement Deficiency Diseases | Preclinical | US | - |